European pharmaceutical company Norgine has relocated its UK office to ARC Uxbridge.
The company has taken 24,000 sq ft of space in the recently refurbished Building 01. The building has received an EPC A and BREEAM Very Good rating and has been designed to create flexible spaces with a focus on wellbeing.
Andrew Davies, leasing director at ARC, said: “We’re delighted to welcome Norgine to ARC Uxbridge and to our wider life sciences cluster. Their decision to join us reflects the growing reputation of ARC as a hub for innovation and excellence in the life sciences sector. With Norgine’s presence, we’re enhancing the collaborative environment within our member community and paving the way for groundbreaking advancements in medical research and development.”
